Clinical Trial Update: High-sensitivity C-reactive Protein and United Kingdom Prospective Diabetes Study (UKPDS) Risk Score in Type 2 Diabetes

View source ↗

Summary

A completed Korea University clinical trial examining how high-sensitivity C-reactive protein relates to the UKPDS risk score in individuals with Type 2 diabete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Korea University | Conditions: Atherosclerosis, Type 2 Diabetes | Status: COMPLETED